| ［1］ |
López-Pingarrón L，Almeida H，Soria-Aznar M，et al. Interstitial cells of cajal and enteric nervous system in gastrointestinal and neurological pathology，relation to oxidative stress［J］. Curr Issues Mol Biol，2023，45（4）：3552-3572.
|
| ［2］ |
Choi EL，Taheri N，Tan E，et al. The crucial role of the interstitial cells of cajal in neurointestinal diseases［J］. Biomolecules，2023，13（9）：1358.
|
| ［3］ |
Corsetti M，Costa M，Bassotti G，et al. First translational consensus on terminology and definitions of colonic motility in animals and humans studied by manometric and other techniques［J］. Nat Rev Gastroenterol Hepatol，2019，16（9）：559-579.
|
| ［4］ |
Spencer NJ，Hibberd TJ，Travis L，et al. Identification of a rhythmic firing pattern in the enteric nervous system that generates rhythmic electrical activity in smooth muscle［J］. J Neurosci，2018，38（24）：5507-5522.
|
| ［5］ |
Li Z，Hao MM，Van den Haute C，et al. Regional complexity in enteric neuron wiring reflects diversity of motility patterns in the mouse large intestine［J］. Elife，2019，8：e42914.
|
| ［6］ |
Kishi K，Kamizaki M，Kaji N，et al. A close relationship between networks of interstitial cells of cajal and gastrointestinal transit in vivo［J］. Front Pharmacol，2020，11：587453.
|
| ［7］ |
Mao YK，Kasper DL. Bacterial interactions with the nervous system［J］. Nat Rev Microbiol，2017，15（10）：563-576.
|
| ［8］ |
Sharkey KA，Mawe GM. Neuroimmune and microbiota interactions in the gut［J］. Nat Rev Gastroenterol Hepatol，2020，17（12）：707-720.
|
| ［9］ |
Mazzoli R，Pessione E. The neuro-endocrinological role of microbial glutamate and GABA signaling［J］. Front Microbiol，2016，7：1934.
|
| ［10］ |
Cryan JF，O'Riordan KJ，Cowan CSM，et al. The microbiota-gut-brain axis［J］. Physiol Rev，2019，99（4）：1877-2013.
|
| ［11］ |
Yano JM，Yu K，Donaldson GP，et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis［J］. Cell，2015，161（2）：264-276.
|
| ［12］ |
Kunze WA，Mao YK，Wang B，et al. Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium-dependent potassium channel opening［J］. J Cell Mol Med，2009，13（8B）：2261-2270.
|
| ［13］ |
Mann ER，Lam YK，Uhlig HH. Short-chain fatty acids：linking diet，the microbiome and immunity［J］. Nat Rev Immunol，2024，24（8）：577-595.
|
| ［14］ |
Rekha K，Venkidasamy B，Samynathan R，et al. Short-chain fatty acid：an updated review on signaling，metabolism，and therapeutic effects［J］. Crit Rev Food Sci Nutr，2024，64（9）：2461-2489.
|
| ［15］ |
Ducastel S，Touche V，Trabelsi MS，et al. The nuclear receptor FXR inhibits Glucagon-Like Peptide-1 secretion in response to microbiotaderived short-chain fatty acids［J］. Sci Rep，2020，10（1）：174.
|
| ［16］ |
Donohoe DR，Garge N，Zhang X，et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon［J］. Cell Metab，2011，13（5）：517-526.
|
| ［17］ |
Nishimura J，Fukunaga S. Butyrate and intestinal barrier function：recent insights into molecular mechanisms［J］. J Physiol Pharmacol，2022，73（3）：487-492.
|
| ［18］ |
Dalile B，Van Oudenhove L，Vervliet B，et al. The role of shortchain fatty acids in microbiota-gut-brain communication［J］. Nat Rev Gastroenterol Hepatol，2019，16（8）：461-478.
|
| ［19］ |
Konopelski P，Mogilnicka I. Biological effects of indole-3-propionic acid，a gut microbiota-derived metabolite，and its precursor tryptophan in mammals' health and disease［J］. Int J Mol Sci，2022，23（3）：1222.
|
| ［20］ |
Buey B，Forcén A，Grasa L，et al. Gut microbiota-derived short-chain fatty acids：novel regulators of intestinal serotonin transporter［J］. Life（Basel），2023，13（5）：1085.
|
| ［21］ |
Wang W，Chen L，Zhou R，et al. Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrateproducing bacteria in inflammatory bowel disease［J］. J Clin Microbiol，2014，52（2）：398-406.
|
| ［22］ |
Hendrikx T，Schnabl B. Indoles：metabolites produced by intestinal bacteria capable of controlling liver disease manifestation［J］. J Intern Med，2019，286（1）：32-40.
|
| ［23］ |
Busbee PB，Rouse M，Nagarkatti M，et al. Indole-3-carbinol （I3C）prevents colitis and restores intestinal integrity in mice through the activation of aryl hydrocarbon receptor （AhR）［J］. Front Immunol，2020，11：1213.
|
| ［24］ |
Nauta A，Scott K，Stahl B，et al. Short chain fatty acids in human gut and metabolic health［J］. Benef Microbes，2020，11（5）：411-455.
|
| ［25］ |
Jin D，Wu S，Zhang Y，et al. Regulation of the formation of short-chain fatty acids from dietary fiber and its impact on human health［J］. Front Microbiol，2019，10：12.
|
| ［26］ |
Guo Z，Wu D. Bile acid diarrhea：from molecular mechanisms to clinical diagnosis and treatment［J］. Int J Mol Sci，2024，25（3）：1544.
|
| ［27］ |
Heinken A，Ravcheev DA，Baldini F，et al. Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease［J］. Microbiome，2019，7（1）：75.
|
| ［28］ |
Fiorucci S，Biagioli M. Bile acid metabolism and signaling in liver disease［J］. J Hepatol，2023，78（1）：251-265.
|
| ［29］ |
Foley MH，O'Flaherty S，Barrangou R，et al. Bile salt hydrolases：gatekeepers of bile acid metabolism and host-microbiome crosstalk in the gastrointestinal tract［J］. PLoS Pathog，2019，15（3）：e1007581.
|
| ［30］ |
Zhang YL，Li ZJ，Gou HZ，et al. The gut microbiota-bile acid axis：a potential therapeutic target for liver fibrosis［J］. Front Cell Infect Microbiol，2022，12：945368.
|
| ［31］ |
Ji Y，Yin Y，Li Z，et al. Gut microbiota-derived components and metabolites in the progression of non-alcoholic fatty liver disease（NAFLD）［J］. Nutrients，2019，11（8）：1712.
|
| ［32］ |
Chen S，Lei Q，Zou X，et al. The role and mechanisms of gramnegative bacterial outer membrane vesicles in inflammatory diseases［J］. Front Immunol，2023，14：1157813.
|
| ［33］ |
Lieberman LA. Outer membrane vesicles：a bacterial-derived vaccination system［J］. Front Microbiol，2022，13：1029146.
|
| ［34］ |
Ismail S，Hampton MB，Keenan JI. Helicobacter pylori outer membrane vesicles modulate proliferation and interleukin-8 production by gastric epithelial cells［J］. Infect Immun，2003，71（10）：5670-5675.
|
| ［35］ |
Lee JC，Lee EJ，Lee JH，et al. Klebsiella pneumoniae secretes outer membrane vesicles that induce the innate immune response［J］. FEMS Microbiol Lett，2012，331（1）：17-24.
|
| ［36］ |
Margutti P，D'Ambrosio A，Zamboni S. Microbiota-derived extracellular vesicle as emerging actors in host interactions［J］. Int J Mol Sci，2024，25（16）：8722.
|
| ［37］ |
Carbonero F，Benefiel AC，Gaskins HR. Contributions of the microbial hydrogen economy to colonic homeostasis［J］. Nat Rev Gastroenterol Hepatol，2012，9（9）：504-518.
|
| ［38］ |
Buret AG，Allain T，Motta JP，et al. Effects of hydrogen sulfide on the microbiome：from toxicity to therapy［J］. Antioxid Redox Signal，2022，36（4-6）：211-219.
|
| ［39］ |
Hoegenauer C，Hammer HF，Mahnert A，et al. Methanogenic archaea in the human gastrointestinal tract［J］. Nat Rev Gastroenterol Hepatol，2022，19（12）：805-813.
|
| ［40］ |
Gasaly N，de Vos P，Hermoso MA. Impact of bacterial metabolites on gut barrier function and host immunity：a focus on bacterial metabolism and its relevance for intestinal inflammation［J］. Front Immunol，2023，14：1187292.
|
| ［41］ |
Naschla G，de Vos P，Hermoso MA. Crosstalk between gut microbiota and host immunity：regulation of intestinal inflammation［J］.Microbiome，2023，11（1）：75.
|
| ［42］ |
Craven DE，Stephens DS，Edwards KM. The role of bacterial products in immune modulation during gut inflammation［J］. Genome Med，2023，15（3）：254-267.
|
| ［43］ |
Chelakkot C，Choi Y，Kim DK，et al. Akkermansia muciniphila-derived extracellular vesicles enhance gut barrier function via upregulation of tight junction proteins［J］. Front Microbiol，2018，9：2179.
|
| ［44］ |
Cani PD，de Vos WM. Next-generation beneficial microbes：the case of Akkermansia muciniphila［J］. Front Microbiol，2017，8：1765.
|
| ［45］ |
Holmberg SM，Feeney RH，Prasoodanan PKV，et al. The gut commensal Blautia maintains colonic mucus function under lowfiber consumption through secretion of short-chain fatty acids［J］. Nat Commun，2024，15（1）：3502.
|
| ［46］ |
van der Post S，Jabbar KS，Birchenough G，et al. Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis［J］. Gut，2019，68（12）：2142-2151.
|
| ［47］ |
Gadaleta RM，van Erpecum KJ，Oldenburg B，et al. Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease［J］. Gut，2011，60（4）：463-472.
|
| ［48］ |
Boekhorst J，Venlet N，Procházková N，et al. Stool energy density is positively correlated to intestinal transit time and related to microbial enterotypes［J］. Microbiome，2022，10（1）：223.
|
| ［49］ |
Letourneau J，Carrion VM，Jiang S，et al. Interplay between particle size and microbial ecology in the gut microbiome［J］. ISME J，2024，18（1）：wrae168.
|
| ［50］ |
Wang J，Zhu N，Su X，et al. Gut-microbiota-derived metabolites maintain gut and systemic immune homeostasis［J］. Cells，2023，12（5）：793.
|
| ［51］ |
Tian H，Zhang S，Qin H，et al. Long-term safety of faecal microbiota transplantation for gastrointestinal diseases in China［J］. Lancet Gastroenterol Hepatol，2022，7（8）：702-703.
|
| ［52］ |
Gu X，Yang Z，Kou Y，et al. Effects of retrograde colonic enemabased fecal microbiota transplantation in the treatment of childhood constipation：a randomized，double-blind，controlled trial［J］. Am J Gastroenterol，2024，119（11）：2288-2297.
|